HALB Stock Chart & Stats
$0.01
<$0.01(4.88%)
At close: 4:00 PM EST
$0.01
<$0.01(4.88%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume347.04K
Average Volume (3M)N/A
Market Cap
$407.54K
Enterprise Value$717.46K
Total Cash (Recent Filing)$5.28K
Total Debt (Recent Filing)$150.00K
Price to Earnings (P/E)―
Beta1.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding515,874,800
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)-5.66
Price to Sales (P/S)4074.31
P/FCF Ratio-78.82
Enterprise Value/Market Cap1.76
Enterprise Value/Revenue718.18
Enterprise Value/Gross Profit14.64K
Enterprise Value/Ebitda-11.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HALB FAQ
What was Halberd Corporation’s price range in the past 12 months?
Currently, no data Available
What is Halberd Corporation’s market cap?
Halberd Corporation’s market cap is $407.54K.
When is Halberd Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Halberd Corporation’s earnings last quarter?
Currently, no data Available
Is Halberd Corporation overvalued?
According to Wall Street analysts Halberd Corporation’s price is currently Overvalued.
Does Halberd Corporation pay dividends?
Halberd Corporation does not currently pay dividends.
What is Halberd Corporation’s EPS estimate?
Halberd Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Halberd Corporation have?
Halberd Corporation has 515,874,800 shares outstanding.
What happened to Halberd Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Halberd Corporation?
Currently, no hedge funds are holding shares in HALB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Halberd Corporation
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.